Escolar Documentos
Profissional Documentos
Cultura Documentos
The online version of this article, along with updated information and services, can be
found online at: http://ptjournal.apta.org/content/92/2/210
Collections
e-Letters
E-mail alerts
Research Report
Early Neuromuscular Electrical
Stimulation to Improve Quadriceps
Muscle Strength After Total Knee
Arthroplasty: A Randomized
Controlled Trial
Jennifer E. Stevens-Lapsley, Jaclyn E. Balter, Pamela Wolfe, Donald G. Eckhoff,
Wendy M. Kohrt
J.E. Stevens-Lapsley, PT, PhD,
Physical Therapy Program, Department of Physical Medicine and
Rehabilitation, University of Colorado, Mail Stop C244, 13121 E
17th Ave, Room 3116, Aurora,
CO 80045 (USA). Address all
correspondence to Dr. StevensLapsley at: jennifer.stevens-lapsley@
ucdenver.edu.
J.E. Balter, MS, Physical Therapy
Program, Department of Physical
Medicine and Rehabilitation, University of Colorado.
P. Wolfe, MS, Department of Preventive Medicine and Biometrics,
University of Colorado.
D.G. Eckhoff, MD, Department
of Orthopedics, University of
Colorado.
W.M. Kohrt, PhD, Division of
Geriatric Medicine, University of
Colorado.
[Stevens-Lapsley JE, Balter JE,
Wolfe P, et al. Early neuromuscular
electrical stimulation to improve
quadriceps muscle strength after
total knee arthroplasty: a randomized controlled trial. Phys Ther.
2012;92:210 226.]
2012 American Physical Therapy
Association
Published Ahead of Print:
November 17, 2011
Accepted: September 30, 2011
Submitted: April 19, 2011
Background. The recovery of quadriceps muscle force and function after total
knee arthroplasty (TKA) is suboptimal, which predisposes patients to disability with
increasing age.
Objective. The purpose of this investigation was to evaluate the efficacy of
quadriceps muscle neuromuscular electrical stimulation (NMES), initiated 48 hours
after TKA, as an adjunct to standard rehabilitation.
Results. At 3.5 weeks after TKA, significant improvements with NMES were found
for quadriceps and hamstring muscle strength, functional performance, and knee
extension active range of motion. At 52 weeks, the differences between groups were
attenuated, but improvements with NMES were still significant for quadriceps and
hamstring muscle strength, functional performance, and some self-report measures.
Limitations. Treatment volume was not matched for both study arms; NMES was
added to the standard of care treatment. Furthermore, testers were not blinded
during testing, but used standardized scripts to avoid bias. Finally, some patients
reached the maximum stimulator output during at least one treatment session and
may have tolerated more stimulation.
Conclusions. The early addition of NMES effectively attenuated loss of quadriceps muscle strength and improved functional performance following TKA. The
effects were most pronounced and clinically meaningful within the first month after
surgery, but persisted through 1 year after surgery.
Physical Therapy
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
Method
Design Overview
This was a randomized, controlled,
parallel-group intervention trial to
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
211
Physical Therapy
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
Figure 1.
Study treatment and testing session timeline. All participants received a similar inpatient, home, and outpatient physical therapy (PT)
regimen. The neuromuscular electrical stimulation (NMES) intervention group also received 6 weeks of NMES treatment at home,
which started 2 days after total knee arthroplasty (TKA) surgery (NMES setup pictured). Participants completed 6 testing sessions
(preoperatively [pre-op] and 3.5, 6.5, 13, 26, and 52 weeks postoperatively [post-op]). The week 3.5 and week 6.5 time points
represent the midpoint and completion of the NMES intervention, respectively, for the NMES group.
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
213
Physical Therapy
torque from the superimposed doublet to the resting doublet allows for
comparisons of quadriceps muscle
activation across individuals and
lower extremities.
Isometric
hamstring
muscle
torque. Isometric hamstring muscle torque was measured using the
same positioning described above,
although no hamstring muscle activation testing was performed. The
trial with the largest maximal volitional isometric force output was
used and was normalized to the participants body weight (in kilograms)
for analysis.
NMES dose assessment. The
NMES training intensity (dose) was
assessed at week 3.5 and week 6.5
testing sessions for participants in
the NMES group. While seated in the
electromechanical
dynamometer,
participants were asked to use their
NMES stimulator at the same intensity used at home. The average electrically elicited (rather than voluntary) torque while the stimulator was
on was recorded across 15 contractions. This average torque then was
expressed as a percentage of the
quadriceps muscles MVIC during
the preoperative session to minimize
the potential for activation deficits to
confound torque measurements.
Functional performance measures. Measures of functional performance included the Timed Up &
Go Test (TUG), the Stair-Climbing
Test (SCT), and the Six-Minute Walk
Test (6MWT). The TUG measures
the time to rise from an armchair,
walk 3 m, turn around, and return
to sitting in the same chair without
physical assistance.35 The minimal
detectable change associated with
the 90% confidence interval (MDC90)
for the TUG in patients 1.5 months
after TKA is 2.49 seconds.36 The SCT
measures the total time to ascend a
flight of stairs, turn around, and
descend. Participants were tested on
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
Control Group
%
Women
20
57.1
16
51.6
Men
15
42.9
15
48.4
X (SD)
X (SD)
Pb
.65
Pb
Age (y)
35
66.2 (9.1)
31
64.8 (7.7)
.49
Height (cm)
35
168.9 (9.3)
31
169.6 (9.6)
.77
Weight (kg)
35
78.0 (17.4)
31
90.0 (17.0)
.01
BMI (kg/m2)
35
27.1 (4.9)
31
31.2 (4.2)
.001
Pedometer (steps/day)
25
5,133 (3,109)
18
4,842 (3,757)
.79
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
215
Randomized (n=66)
Pre-OP
3.5 wk
6.5 wk
13 wk
26 wk
52 wk
Figure 2.
Recruitment, enrollment, and adherence of study participants. Enrollment numbers and withdrawals or those lost to follow-up are
indicated in the boxes between time points. Overall, the total number of participants lost to follow-up through 52 weeks were 5 in
the neuromuscular electrical stimulation (NMES) group and 6 in the control group. DVTdeep venous thrombosis, TKAtotal knee
arthroplasty, C-Diffclostridium difficile, pre-oppreoperatively, post-oppostoperatively.
Physical Therapy
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
NMES Group
Control Group
Pc
0.40 (0.05)
0.67 (0.06)
.001
0.25 (0.03)
0.35 (0.04)
.04
34.7 (15.5)
137 (18.3)
.001
Variable
8.9 (2.8)
22.2 (3.0)
.001
1.5 (0.6)
4.2 (0.7)
.003
5.2 (3.3)
2.9 (3.7)
.09
2.2 (0.8)
5.2 (0.9)
.01
26.4 (2.1)
25.5 (2.2)
.75
3.9 (3.3)
7.9 (3.8)
.02
0.0 (1.6)
1.1 (1.8)
.65
0.3 (1.6)
3.9 (1.8)
.12
11.9 (2.7)
6.9 (2.9)
.18
1.0 (0.4)
0.6 (0.4)
.50
NMESneuromuscular electrical stimulation, CIconfidence interval, SF-3636-Item Short-Form Health Survey questionnaire, PCSPhysical Component
Score, MCSMental Component Score, WOMACWestern Ontario and McMaster Universities Osteoarthritis Index.
b
Values are means standard error of the estimate. Negative values reflect a deficit from baseline; positive values reflect an improvement from baseline.
c
P values are from the estimated between-group difference in change from baseline, conditioned on baseline. The model is change from baseline regressed
on baseline and treatment assignment.
d
Normalized to weight.
Results
Five hundred twenty-six patients
scheduled for TKA at the University
of Colorado Hospital were assessed
for eligibility. Fifty-nine patients
were unable to be contacted, 365
did not meet the inclusion criteria,
and 36 declined to participate. Of
those who were ineligible, 11% were
not between the ages of 50 to 85
years, 13% had a BMI of greater than
35 kg/m2, 31% had moderate to
severe contralateral pain or staged
TKAs within 6 months of each other,
7% had other orthopedic conditions
that limited their function, 8% were
smokers, 7% had uncontrolled diabetes or neuropathy, and 23% had
February 2012
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
217
218
Physical Therapy
1.32 (0.49),
n31
1.33 (0.57),
n35
1.5 (4.0),
n31
54.2 (21.5),
n26
76.4 (14.8),
n34
18.1 (10.9),
n35
9.0 (4.2),
n35
404.2 (128.2),
n35
123.3 (13.7),
n35
0.6 (3.2),
n35
60.2 (24.8),
n29
2.5 (1.9),
n30
36.9 (12.3),
n34
38.3 (9.2),
n34
54.6 (9.9),
n34
Quadriceps
muscle
activation
(%)
Stair-Climbing
Test (s)
Timed Up &
Go Test (s)
Six-Minute
Walk Test
(m)
Flexion AROM
()
Extension
AROM ()
Global rating
scale
(points)
Resting pain
(points)
WOMAC total
(points)
SF-36 PCS
(points)
SF-36 MCS
(points)
10.4 (3.8),
n31
25.2 (10.4),
n30
82.3 (17.2),
n30
0.49 (0.18),
n30
0.93 (0.41),
n31
NMES
Group
13.9 (4.5),
n28
39.3 (21.1),
n28
73.6 (17.9),
n26
0.39 (0.19),
n28
0.66 (0.24),
n28
Control
Group
3.5 Weeks
Postoperatively
8.0 (2.1),
n31
16.5 (7.2),
n31
84.9 (13.7),
n31
0.65 (0.23),
n31
1.20 (0.47),
n31
NMES
Group
11.3 (6.8),
n26
23.5 (17.1),
n26
86.3 (10.6),
n24
0.55 (0.20),
n28
1.04 (0.35),
n28
Control
Group
6.5 Weeks
Postoperatively
7.5 (2.2),
n30
13.6 (7.1),
n30
86.5 (12.9),
n30
0.73 (0.21),
n29
1.42 (0.52),
n30
NMES
Group
9.5 (2.8),
n30
16.3 (7.5),
n30
85.4 (11.5),
n29
0.65 (0.24),
n30
1.20 (0.42),
n29
Control
Group
13 Weeks
Postoperatively
7.1 (2.0),
n31
12.1 (5.1),
n31
88.4 (10.1),
n31
0.79 (0.25),
n31
1.51 (0.48),
n31
NMES
Group
8.6 (2.1),
n26
14.8 (7.8),
n26
84.2 (10.0),
n26
0.72 (0.25),
n27
1.39 (0.44),
n27
Control
Group
26 Weeks
Postoperatively
6.7 (1.7),
n29
11.5 (4.3),
n29
87.6 (9.2),
n30
0.83 (0.25),
n30
1.66 (0.52),
n30
NMES
Group
8.3 (2.8),
n25
14.8 (9.3),
n25
85.9 (11.9),
n23
0.72 (0.29),
n25
1.50 (0.43),
n25
Control
Group
52 Weeks
Postoperatively
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
55.0 (9.6),
n28
36.3 (9.4),
n28
26.6 (12.0),
n28
1.8 (1.7),
n30
51.0 (11.5),
n22
35.8 (7.3),
n22
31.4 (14.1),
n21
2.1 (1.8),
n26
50.2 (17.2),
n23
6.4 (5.2),
n28
95.2 (11.9),
n28
56.8 (9.4),
n28
43.0 (7.9),
n28
18.1 (8.9),
n29
0.6 (0.9),
n29
75.5 (11.3),
n28
53.7 (7.5),
n23
42.9 (6.4),
n23
23.7 (14.2),
n24
1.2 (1.3),
n24
73.0 (18.8),
n22
57.9 (8.2),
n25
49.0 (7.6),
n25
11.2 (8.7),
n26
0.6 (1.2),
n30
85.9 (10.9),
n28
54.2 (9.7),
n21
45.8 (8.5),
n21
18.0 (17.6),
n21
1.5 (2.1),
n26
80.8 (19.4),
n26
1.6 (3.8),
n30
57.2 (4.4),
n28
52.2 (5.2),
n28
7.5 (6.6),
n28
0.6 (1.3),
n30
89.8 (9.9),
n30
0.5 (3.7),
n31
2.9 (4.3),
n26
0.8 (2.8),
n30
1.2 (4.0),
n31
55.2 (7.6),
n21
48.3 (7.6),
n21
13.6 (11.6),
n21
0.7 (1.5),
n25
85.2 (14.9),
n26
0.1 (2.9),
n25
57.8 (4.4),
n27
52.6 (5.9),
n27
5.7 (5.9),
n26
0.6 (1.4),
n29
95.6 (5.7),
n30
2.0 (3.5)
n30
54.8 (6.9),
n21
50.7 (7.4),
n21
10.0 (12.2),
n21
0.4 (1.5),
n23
87.3 (15.0),
n25
1.4 (3.4),
n25
117.0 (9.1),
n25
a
NMESneuromuscular electrical stimulation, AROMactive range of motion, WOMACWestern Ontario and McMaster Universities Osteoarthritis Index, SF-3636-Item Short-Form Health Survey
questionnaire.
b
Normalized to body weight.
52.2 (12.0),
n29
33.4 (7.4),
n29
42.0 (13.7),
n30
2.7 (2.4),
n28
60.5 (17.5),
n28
2.6 (3.6),
n31
433.6 (99.2), 390.1 (92.4), 295.3 (103.4), 466.6 (93.0), 388.0 (94.9), 495.7 (95.6), 433.1 (88.9), 496.2 (104.3), 465.8 (83.9), 524.6 (81.6), 477.8 (94.0),
n31
n31
n24
n31
n24
n30
n29
n31
n26
n29
n25
10.1 (3.6),
n31
20.2 (12.3),
n31
75.5 (19.0),
n29
0.76 (0.28),
n35
0.72 (0.26),
n31
Control
Group
NMES
Group
Hamstring
muscle
strengthb
(N-m/kg)
Quadriceps
femoris
muscle
strengthb
(N-m/kg)
Variable
Preoperatively
Mean (SD) Values for Strength and Functional Performance Outcome Measuresa
Table 3.
February 2012
D
*
1.6
35
1.4
30
Time (s)
40
1.2
1.0
45
1.8
10
0.4
NMES
Control
Time Point
16
0.9
1.0
14
0.8
Time (s)
12
0.7
0.6
10
w
52 k
w
k
26
13
k
w
5
3.
6.
op
Pr
e-
26
13
5
6.
3.
ePr
52 k
w
k
0.3
0.4
0.5
op
Pr
eop
3.
5
w
6. k
5
w
k
13
w
k
26
w
52 k
w
k
0.6
Time Point
Time Point
Time Point
95
600
550
Distance (m)
90
85
80
75
500
450
400
Pr
26
13
6.
3.
5
ePr
Time Point
52 k
w
k
250
65
300
70
eop
3.
5
w
6. k
5
w
k
13
w
k
26
w
52 k
w
k
350
op
Activation (%)
20
15
25
0.8
Pr
eop
3.
5
w
6. k
5
w
k
13
w
k
26
w
52 k
w
k
2.0
Time Point
Figure 3.
Changes in strength and functional performance over time (mean standard error of the mean) in the neuromuscular electrical
stimulation (NMES) group (black circles) and the control group (white circles): (A) quadriceps femoris muscle maximum voluntary
isometric contraction (MVIC) normalized to body weight, (B) hamstring muscle MVIC normalized to body weight, (C) quadriceps
muscle central activation, (D) Stair-Climbing Test, (E) Timed Up & Go Test, (F) Six-Minute Walk Test. Significant differences
between groups are indicated by asterisks (P.05). Pre-oppreoperatively.
February 2012
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
219
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
Overall
26 (83.9%)
26 (83.9%)
24 (77.4%)
19 (61.3%)
20 (64.5%)
18 (58.1%)
24 (77.4%)
4 (12.9%)
3 (9.7%)
6 (19.4%)
7 (23%)
6 (19.4%)
6 (19.4%)
6 (19.4%)
0 (0.0%)
1 (3.2%)
0 (0.0%)
1 (3.2%)
1 (3.2%)
2 (6.5%)
0 (0.0%)
No records
1 (3.2%)
1 (3.2%)
1 (3.2%)
4 (12.9%)
4 (12.9%)
5 (16.1%)
1 (3.2%)
Adherent (80%)
Treatment adherence is reported as the number of participants, and the percentage of the total number of participants who received neuromuscular
electrical stimulation (NMES) is noted in parentheses. Treatment adherence was based on the percentage of expected home NMES treatment. The
expectation was 15 contractions per session, 2 sessions per day, 6 7 days per week.
Discussion
The addition of NMES treatment to
the quadriceps muscles effectively
attenuated loss of quadriceps muscle
strength and improved functional
performance
following
TKA.
Although the effects were most pronounced and clinically meaningful
within the first month after surgery,36,33 benefits persisted through
1 year after surgery. Notably, 3.5
weeks after TKA, NMES application
substantially attenuated loss of quadriceps muscle strength (67% loss in
control group and 40% loss in NMES
group). This finding translated into
even greater attenuation of functional performance deficits, with
changes in the 6MWT distance at 3.5
weeks being the most notable (loss
of 137 m in the control group and
loss of 34.7 m in the NMES group).
Self-report measures of physical
function (SF-36, WOMAC) did not
demonstrate early improvements
with NMES treatment, whereas
220
Physical Therapy
performance-based measures of
physical function (TUG, SCT,
6MWT) did show improvements.
These findings were expected
because patient perception fails to
capture the acute functional declines
after TKA and may overstate the
long-term functional improvement
with surgery, largely because
patient-reported outcomes typically
parallel pain relief after surgery.48,50
In 2003, a National Institutes of
Health consensus statement on total
knee replacement stated that the
use of rehabilitation services is perhaps the most understudied aspect
of the perioperative management of
TKA patients.51(p15) Yet, since 2003,
few studies have provided additional
guidelines for evidence-based rehabilitation following TKA.52 One
large-scale clinical trial with a progressive exercise program involving
6 weeks of outpatient physical therapy 2 to 3 times per week demonstrated a 38% faster SCT time, a 17%
increase in 6MWT distance, and a
24% increase in quadriceps muscle
strength 1 year after TKA compared
with standard care.24 These findings
were despite the fact that the progressive component of the intervention was initiated 3 to 4 weeks after
TKA, when large strength and functional losses had already occurred.
Using rehabilitation strategies such
as NMES immediately after surgery
may be more effective because preventing the decline of muscle func-
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
221
Physical Therapy
Conclusion
The addition of quadriceps muscle
NMES initiated within 48 hours after
TKA attenuated loss of quadriceps
muscle strength 3.5 weeks after TKA
and improved functional performance; benefits of NMES treatment
persisted through 1 year. Functional
performance for the NMES group at
1 year began to approach outcomes
for older adults who were healthy,
tested using identical methods,9 yet
they still lagged behind in clinically
meaningful differences in TUG, SCT,
and 6MWT performance.36 Even the
control group in this study exceeded
outcomes previously reported in
the literature,52 yet they lagged even
further behind adults who were
healthy compared with the NMES
group. Therefore, further research
focused on early intervention after
TKA is warranted to continue to
optimize patient outcomes.
Dr Stevens-Lapsley, Ms Balter, Dr Eckhoff,
and Dr Kohrt provided concept/idea/
research design. Dr Stevens-Lapsley, Ms Balter, and Ms Wolfe provided writing and data
analysis. Dr Stevens-Lapsley and Ms Balter
provided data collection and project management. Dr Stevens-Lapsley and Dr Kohrt
provided fund procurement. Dr Eckhoff provided participants. Dr Stevens-Lapsley provided facilities/equipment. Dr Eckhoff and
Dr Kohrt provided consultation (including
review of manuscript before submission).
The authors acknowledge Dana Judd, PT,
DPT, for assistance with patient testing and
treatment; Roger Enoka, PhD, John Kittelson,
PhD, Margaret Schenkman, PT, PhD, and
Robert Schwartz, MD, for consultation and
guidance on research design and implementation; Ben Shulman, BS, for statistical analyses; and Tami Struessel, PT, DPT, for consultation and guidance on physical therapy
interventions. They also thank the physical
therapists at the University of Colorado
Hospital.
References
1 Centers for Disease Control and Prevention. Arthritis: data and statistics. Available at: http://www.cdc.gov/arthritis/
data_statistics.htm. Accessed November
23, 2010.
2 Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project
(HCUP). HCUP facts and figures: statistics
on hospital-based care in the United
States, 2008. Available at: http://www.
hcup-us.ahrq.gov/reports/factsandfigures/
2008/TOC_2008.jsp. Accessed January 18,
2011.
3 Kurtz S, Ong K, Lau E, et al. Projections of
primary and revision hip and knee arthroplasty in the United States from 2005 to
2030. J Bone Joint Surg Am. 2007;89:
780 785.
4 Silva M, Shepherd EF, Jackson WO, et al.
Knee strength after total knee arthroplasty. J Arthroplasty. 2003;18:605 611.
5 Walsh M, Woodhouse LJ, Thomas SG,
Finch E. Physical impairments and functional limitations: a comparison of individuals 1 year after total knee arthroplasty
with control subjects. Phys Ther. 1998;78:
248 258.
6 Noble PC, Gordon MJ, Weiss JM, et al.
Does total knee replacement restore normal knee function? Clin Orthop Relat Res.
2005:157165.
7 Mizner RL, Petterson SC, Stevens JE, et al.
Early quadriceps strength loss after total
knee arthroplasty: the contributions of
muscle atrophy and failure of voluntary
muscle activation. J Bone Joint Surg Am.
2005;87:10471053.
8 Stevens JE, Mizner RL, Snyder-Mackler L.
Quadriceps strength and volitional activation before and after total knee arthroplasty for osteoarthritis. J Orthop Res.
2003;21:775779.
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
February 2012
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
223
224
Physical Therapy
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
Middle
February 2012
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
Physical Therapy f
225
226
Physical Therapy
Volume 92 Number 2
Downloaded from http://ptjournal.apta.org/ by guest on December 21, 2014
February 2012
References
Cited by
Subscription
Information
http://ptjournal.apta.org/site/misc/ifora.xhtml